What is AFLAC's primary business and geographical focus?

AFLAC Incorporated's primary business is supplemental health and life insurance. Its operations are significantly focused on Japan, which constituted the majority of its revenues and assets. The company is also a leading provider of cancer expense insurance globally.

How did currency fluctuations affect AFLAC's financial results?

The strengthening of the Japanese yen against the U.S. dollar in 2000 and 1999 had a positive impact on AFLAC's reported operating earnings per share. The report notes that the stronger yen increased operating earnings per share by $0.02 in 2000 compared to 1999, and by $0.06 in 1999 compared to 1998.

What significant non-operating factors impacted AFLAC's net earnings in 2000?

In 2000, AFLAC's net earnings were affected by several non-operating items. These included a gain of $101 million from the release of an accrued unfunded retirement liability, and investment security losses totaling $58 million ($.11 per share) due to credit rating downgrades and sales at a loss.

What is the company's strategy regarding its Japanese operations amidst economic challenges?

Despite Japan's depressed economy and low investment yields, AFLAC Japan has maintained a strong position through its unique distribution system and focus on supplemental insurance. The company has also diversified its product offerings and adjusted to regulatory changes, including increased competition in the third sector of the insurance market.

AFL 10-K FY2000 Annual Report — Revenue, Net Income, EPS

Summary

AFLAC Incorporated's 2000 Form 10-K reveals a company heavily reliant on its Japanese operations, which accounted for approximately 81% of total revenues and 86% of total assets. The company primarily operates in supplemental health and life insurance, with a leading position in cancer expense insurance globally. The report highlights the impact of foreign currency fluctuations, particularly the strengthening yen, which positively affected operating earnings per share. Significant non-operating items influenced net earnings, including a gain from releasing a retirement liability and losses on investment securities in 2000, as well as deferred tax benefits from Japanese corporate income tax rate reductions and charges for a Japanese policyholder protection fund in prior years.

Key Highlights

1AFLAC's business is significantly concentrated in Japan, representing 81% of revenues and 86% of assets, highlighting the importance of its international segment.
2The company is a global leader in cancer expense insurance and offers a diversified range of supplemental health and life products in both Japan and the U.S.
3The strengthening yen in 2000 and 1999 positively impacted operating earnings per share, demonstrating the sensitivity of reported results to currency exchange rates.
4Significant non-operating events, such as a retirement liability release and investment security losses in 2000, and tax rate reductions and policyholder protection fund charges in prior years, affected net earnings.
5Annualized premiums in force showed growth in both Japan and the U.S. over the three-year period, with Japan's premiums in force at $6,452 million and U.S. at $1,862 million by the end of 2000.
6The company maintains a strong investment portfolio with a focus on high-quality fixed maturities, with AFLAC Japan holding 99.4% of its debt securities in investment grade as of March 31, 2000.
7A two-for-one stock split was declared in February 2001, with shares adjusted accordingly in the filing.

AFLAC INC Annual Report, Year Ended Dec 31, 2000

Summary

Key Highlights

Frequently Asked Questions